User: Can you estimate the half life time in humans after IV administration for the molecule with the SMILES N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O?
Assistant: Based on my analysis, the half life time in humans after IV administration for this molecule is approximately 4.200 hours.
User: Can you {#tell me|derive|estimate!} the {half_life_duration__names__noun} for the molecule with the {SMILES__description} {SMILES#}?
Assistant: Based on my analysis, the {half_life_duration__names__noun} for this molecule is approximately {half_life_duration#} {half_life_duration__units}.
2-[(3S,6S,12S,20R,23S)-20-aminocarbonyl-12-(4-carbamimidamidobutyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexakis(oxidanylidene)-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]ethanoicacid